FACT FOCUS: Trump blames other countries for high US drug prices. Experts say it’s not their fault
- President Donald Trump signed an executive order on a Monday in 2024 to lower U.S. Prescription drug prices by linking them to lower prices abroad.
- This order responds to concerns that U.S. Drug prices exceed those in other high-income countries due to the fragmented negotiation system within the U.S. Market.
- The RAND report found that in 2022 the U.S. Paid 2.78 times more for drugs than 33 comparable countries, making up 62% of drug sales but only 24% of volume studied.
- Experts including Mariana Socal and Courtney Yarbrough explained that structural differences in negotiation and market power drive higher U.S. Prices, with no party in the industry acting as a saint.
- The order requires drugmakers to lower prices in 30 days or face new federal rules tying U.S. Prices to those abroad, though the impact on privately insured Americans remains unclear.
63 Articles
63 Articles


Trump Blames Other Nations for U.S. Drug Prices. Experts Say It's Not Their Fault.
(MedPage Today) -- President Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an executive order intended to lower their cost. The order sets a 30-day...

FACT FOCUS: Trump blames other countries for high US drug prices. Experts say it’s not their fault
By MELISSA GOLDIN President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an executive order intended to lower their cost. Related Articles Americans are divided over DEI programs on college campuses, poll finds Trump’s sanctions on ICC prosecutor have halted tribunal’s work Older people in crossha…
'It does nothing': Trump's 'surreal parallel universe' plan burned down on MSNBC
According to financial analyst Steve Rattner, Donald Trump's executive order demanding prescription drug prices must go down was a nothing-burger that is not worth the paper it was written on.Appearing on MSNBC's "Morning Joe," Rattner pointed to the signing by Trump, who called it one of the most "...
Pharmaceuticals in the face of Trump’s scourge: which companies best face the price cut of medicines
The pharmaceutical companies lost on Monday part of the bullish feast that left on the Stock Exchange the tariff truce agreed between the United States and China. They started the day with sharp falls, up to 8% for Novo Nordisk, after Donald Trump announced the signing of an executive order to lower the price of the drugs paid by the US federal government by 30% to 80%, but those declines remained almost nothing at the end of the session. The qu…
Trump declared war on drug dealers: His policies are killing drug users
Trump sold his border and tariff policies in part as a way to reduce the death of drug users in the US. Yet his domestic drug policies are putting users' lives at risk. He may have created MAGA, but in this duplicity, Trump is a traditional Republican....


Will Trump’s Executive Order Lower Prescription Drug Prices?
The cost of prescription drugs in the U.S. has long outpaced that of peer nations, a dynamic driven by a combination of regulatory gaps, market forces, and lobbying pressure. Now, President Donald Trump is once again trying to tackle the issue—this time through an Executive Order that aims to pressure pharmaceutical companies to voluntarily lower their prices. [time-brightcove not-tgx=”true”] On Monday, President Donald Trump signed the Executiv…
Coverage Details
Bias Distribution
- 46% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage